Arlene Chan

Arlene has practiced public accounting since 1993. Arlene primarily works with computer hardware, biotechnology, pharmaceutical drug discovery, and medical device companies. She consults clients in the application and implementation of new accounting policies and technical guidance in compliance with SEC, SOX 404, and US GAAP requirements. In addition, she has led numerous initial and subsequent public offerings and merger and acquisition activities including due diligence, and related accounting and SEC reporting. Before joining the firm, Arlene spent 14 years with a Big Four firm, including two years in Singapore.